Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Pros Regulatory News (GPM)

Share Price Information for Golden Pros (GPM)

Share Price is delayed by 15 minutes
Get Live Data
113.00    -0.50 (-0.44%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £111.66m
GPM Live PriceLast checked at - London Stock Exchange

Intraday Golden Pros Share Chart

Board Changes and Director Declaration

26 Mar 2026 07:00

RNS Number : 1498Y
Golden Prospect Precious Metals Ltd
26 March 2026
Β 

26 March 2026

Golden Prospect Precious Metals Limited (the "Company" or "GPM")

Β 

Board Changes and Director Declaration

Β 

The Board of the Company is pleased to announce that Christopher Waldron has been appointed as a Non-Executive Director and member of GPM's Audit, Management Engagement, and Remuneration & Nomination Committees with effect from 26 March 2026.

Mr Waldron, aged 61, is a resident of Guernsey. He is Chair of Crystal Amber Fund Limited and a director of Bluefield Solar Income Fund as well as a number of unlisted companies. He has over 35 years' experience as an investment manager and until 2013 was Chief Executive of the Edmond de Rothschild Group in the Channel Islands. Mr Waldron previously held investment management positions with James Capel, Bank of Bermuda, the Jardine Matheson Group and Fortis. A graduate of the University of London and Cranfield University, he is a Fellow of the Chartered Institute of Securities and Investment.

The Board of Directors considers Mr Waldron to be independent on appointment per the AIC Corporate Governance Code.

Toby Birch, Chairman, commented:

"I am pleased to welcome Chris as an Independent Non-Executive Director of the Company. His extensive investment management experience and leadership roles within listed and unlisted companies will bring significant insight and depth to GPM's governance and strategic oversight."

Directors' Declarations Pursuant to Rule 6.4.8R of the UK Listing Rules

Β 

Mr Waldron is currently a director of the below public companies:

Β 

Β· Bluefield Solar Income Fund Ltd; and

Β· Crystal Amber Fund Limited.

Β 

Within the last five years, Mr Waldron has been but is no longer a director of the below public company:

Β· UK Mortgages Limited.

Β 

There are no further disclosures required under Rule 6.4.8R of the UK Listing Rules in respect of Mr Waldron.

Β 

Β 

Enquiries

Β 

Apex Fund and Corporate Services (Guernsey) Limited

James Taylor

Β 

+44 (0) 203 5303 600

GPPMCoSec@apexgroup.com

Β 

About Golden Prospect Precious MetalsΒ 

Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability inΒ GuernseyΒ on 16 October 2006. The Company's investment objective is to provide Shareholders with capital growth from a portfolio of companies involved in the precious metals sector. For the latest factsheet and other information, clickβ€―here.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAPPUUPWUPQGMA
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 202612:07 pmRNSNet Asset Value(s)
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20261:17 pmRNSNet Asset Value(s)
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20262:03 pmRNSNet Asset Value(s)
1st Jun 20261:13 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 202611:59 amRNSNet Asset Value(s)
29th May 20267:00 amRNSTransaction in Own Shares
28th May 202612:36 pmRNSNet Asset Value(s)
28th May 20267:00 amRNSTransaction in Own Shares
27th May 202611:49 amRNSNet Asset Value(s)
27th May 20269:30 amRNSTransaction in Own Shares
26th May 20264:44 pmRNSMonthly Investor Report - April 2026
26th May 20261:38 pmRNSNet Asset Value(s)
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20264:34 pmRNSCorrection of Diluted Net Asset Value per Share
22nd May 202612:11 pmRNSNet Asset Value(s)
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 202612:09 pmRNSNet Asset Value(s)
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20261:50 pmRNSNet Asset Value(s)
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20264:54 pmRNSNet Asset Value(s)
19th May 20267:00 amRNSPortfolio Management Update
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20262:48 pmRNSNet Asset Value(s)
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20263:09 pmRNSNet Asset Value(s)
15th May 20267:00 amRNSTransaction in Own Shares
14th May 202612:29 pmRNSNet Asset Value(s)
14th May 20267:00 amRNSNotice of Annual General Meeting & Form of Proxy
14th May 20267:00 amRNSTransaction in Own Shares
13th May 202612:54 pmRNSNet Asset Value(s)
13th May 20267:00 amRNSTransaction in Own Shares
12th May 202612:03 pmRNSNet Asset Value(s)
11th May 20261:56 pmRNSNet Asset Value(s)
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20261:17 pmRNSNet Asset Value(s)
8th May 20267:00 amRNSTransaction in Own Shares
7th May 202611:55 amRNSNet Asset Value(s)
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20261:06 pmRNSNet Asset Value(s)
6th May 20267:00 amRNSTransaction in Own Shares
5th May 202612:11 pmRNSNet Asset Value(s)
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20261:21 pmRNSNet Asset Value(s)
1st May 202612:00 pmRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.